Home › NDC Lookup › RxCUI directory › RxCUI 1658325

Brexpiprazole 0.25 MG Oral Tablet [Rexulti] — RxCUI 1658325

RxNorm drug concept · Semantic branded drug
RxCUI 1658325 Semantic branded drug · SBD ● Current RxNorm concept 8 FDA products 13 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1658325
Official nameBrexpiprazole 0.25 MG Oral Tablet [Rexulti]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asRexulti 0.25 MG Oral Tablet
FDA products mapped8
Package NDCs mapped13
Reported Medicaid activity (SDUD)344,798 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Brexpiprazole: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It's not a traditional antidepressant on its own. Brexpiprazole is an atypical antipsychotic, but it's approved to be added on to an antidepressant when the antidepressant alone is...
  • What is brexpiprazole actually used for — and is it an antidepressant?
  • It typically takes 10 to 12 days of daily dosing for brexpiprazole to build up to stable levels in your body, and your prescriber will usually start you at a low dose and increase...
  • The most common ones people notice are weight gain, sleepiness, a restless urge to move (called akathisia), headache, and trouble sleeping. Most of these are manageable and worth d...
📖 Read our full Brexpiprazole guide →

🕸️ Concept Web — How Brexpiprazole 0.25 MG Oral Tablet [Rexulti] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Brexpiprazole 0.25 MG Oral Tablet [Rexulti] RxCUI 1658325

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Brexpiprazole 1658314
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Rexulti 1658320
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Brexpiprazole Oral Tablet 1658318
    • Brexpiprazole Oral Product 1658316
    • Brexpiprazole Pill 1658317
    • Brexpiprazole Oral Tablet [Rexulti] 1658322
    • Rexulti Oral Product 1658323
    • Rexulti Pill 1658324
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Brexpiprazole 0.25 MG Oral Tablet SCD · 1658319
  • Brexpiprazole 0.25 MG SCDC · 1658315
  • Brexpiprazole Oral Tablet SCDF · 1658318
  • Brexpiprazole Oral Product SCDG · 1658316
  • Brexpiprazole Pill SCDG · 1658317

Brand-Name Concepts

  • Brexpiprazole 0.25 MG [Rexulti] SBDC · 1658321
  • Brexpiprazole Oral Tablet [Rexulti] SBDF · 1658322
  • Rexulti Oral Product SBDG · 1658323
  • Rexulti Pill SBDG · 1658324
  • Rexulti BN · 1658320

📦 FDA Products & Package NDCs

8 products · 13 package NDCs
13 package NDCs map to RxCUI 1658325 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
59148-0035-13 1 BOTTLE in 1 CARTON (59148-035-13) / 30 TABLET in 1 BOTTLE Rexulti Otsuka America Pharmaceutical, Inc. 2015-07-10
59148-0036-07 1 BLISTER PACK in 1 CARTON (59148-036-07) / 7 TABLET in 1 B... Rexulti Otsuka America Pharmaceutical, Inc. 2015-07-10
59148-0036-13 1 BOTTLE in 1 CARTON (59148-036-13) / 30 TABLET in 1 BOTTLE Rexulti Otsuka America Pharmaceutical, Inc. 2015-07-10
59148-0037-07 1 BLISTER PACK in 1 CARTON (59148-037-07) / 7 TABLET in 1 B... Rexulti Otsuka America Pharmaceutical, Inc. 2015-07-10
59148-0037-13 1 BOTTLE in 1 CARTON (59148-037-13) / 30 TABLET in 1 BOTTLE Rexulti Otsuka America Pharmaceutical, Inc. 2015-07-10
59148-0038-07 1 BLISTER PACK in 1 CARTON (59148-038-07) / 7 TABLET in 1 B... Rexulti Otsuka America Pharmaceutical, Inc. 2015-07-10
59148-0038-13 1 BOTTLE in 1 CARTON (59148-038-13) / 30 TABLET in 1 BOTTLE Rexulti Otsuka America Pharmaceutical, Inc. 2015-07-10
59148-0039-07 1 BLISTER PACK in 1 CARTON (59148-039-07) / 7 TABLET in 1 B... Rexulti Otsuka America Pharmaceutical, Inc. 2015-07-10
59148-0039-13 1 BOTTLE in 1 CARTON (59148-039-13) / 30 TABLET in 1 BOTTLE Rexulti Otsuka America Pharmaceutical, Inc. 2015-07-10
59148-0040-07 1 BLISTER PACK in 1 CARTON (59148-040-07) / 7 TABLET in 1 B... Rexulti Otsuka America Pharmaceutical, Inc. 2015-07-10
59148-0040-13 1 BOTTLE in 1 CARTON (59148-040-13) / 30 TABLET in 1 BOTTLE Rexulti Otsuka America Pharmaceutical, Inc. 2015-07-10
59148-0042-07 1 KIT in 1 CARTON (59148-042-07) * 4 TABLET in 1 BLISTER P... Rexulti Otsuka America Pharmaceutical, Inc. 2015-07-10
59148-0044-14 1 KIT in 1 CARTON (59148-044-14) * 7 TABLET in 1 BLISTER P... Rexulti Otsuka America Pharmaceutical, Inc. 2015-07-10
Observed labelers: Otsuka America Pharmaceutical, Inc. (13) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.